Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Oxford BioDynamics ( (GB:OBD) ) is now available.
Unicorn Asset Management Limited has significantly reduced its holdings in Oxford BioDynamics, as indicated by the notification of major holdings. The voting rights percentage held by Unicorn Asset Management decreased from 23% to 7.41%, signaling a major shift in shareholder composition. This change could impact the company’s market dynamics and investor relations.
More about Oxford BioDynamics
Oxford BioDynamics is a biotechnology company focused on developing and commercializing molecular diagnostic products. The company is known for its expertise in epigenetic biomarkers and aims to enhance personalized medicine through its innovative solutions.
YTD Price Performance: -66.67%
Average Trading Volume: 3,491,952
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.76M
For a thorough assessment of OBD stock, go to TipRanks’ Stock Analysis page.